Payment overview · 2025
General Payments
$18.84
1 reported records · 1 companies
Healthcare provider profile · identity verified
Charles D Nyhus, MD
Allopathic & Osteopathic Physicians|Family Medicine · HARVEY, ND · NPI 1700954633
Verified facts
What the public records show
CMS Open Payments records show Charles D Nyhus, MD received $18.84 in general payments during 2025 across 1 reported records.
Vanda Pharmaceuticals Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $18.84 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $18.84 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| FANAPT Normalized: fanapt |
Drug | Vanda Pharmaceuticals Inc. | $18.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Lisinopril | Lisinopril | 253 | 62 |
| Atorvastatin Calcium | Atorvastatin Calcium | 236 | 60 |
| Amlodipine Besylate | Amlodipine Besylate | 224 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 198 | 61 |
| Metformin Hcl | Metformin Hcl | 192 | 46 |
| Metoprolol Succinate | Metoprolol Succinate | 175 | 42 |
| Furosemide | Furosemide | 168 | 50 |
| Levothyroxine Sodium | Levothyroxine Sodium | 138 | 27 |
| Metoprolol Tartrate | Metoprolol Tartrate | 128 | 25 |
| Tramadol Hcl | Tramadol Hcl | 123 | 34 |
| Escitalopram Oxalate | Escitalopram Oxalate | 112 | 24 |
| Omeprazole | Omeprazole | 108 | 28 |
| Pantoprazole Sodium | Pantoprazole Sodium | 108 | 30 |
| Lorazepam | Lorazepam | 107 | 29 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 99 | 27 |
| Sertraline Hcl | Sertraline Hcl | 98 | 18 |
| Losartan Potassium | Losartan Potassium | 96 | 28 |
| Potassium Chloride | Potassium Chloride | 93 | 24 |
| Eliquis | Apixaban | 83 | 14 |
| Meloxicam | Meloxicam | 82 | 17 |
| Hydrochlorothiazide | Hydrochlorothiazide | 81 | 23 |
| Simvastatin | Simvastatin | 76 | 20 |
| Prednisone | Prednisone | 74 | 42 |
| Alprazolam | Alprazolam | 71 | 11 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 71 | 14 |
| Gabapentin | Gabapentin | 70 | 21 |
| Clopidogrel | Clopidogrel Bisulfate | 67 | 14 |
| Allopurinol | Allopurinol | 58 | 19 |
| Jardiance | Empagliflozin | 55 | suppressed |
| Cephalexin | Cephalexin | 53 | 44 |
| Warfarin Sodium | Warfarin Sodium | 52 | 12 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 51 | 39 |
| Azithromycin | Azithromycin | 45 | 37 |
| Doxazosin Mesylate | Doxazosin Mesylate | 44 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 44 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 41 | 11 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 41 | 41 |
| Finasteride | Finasteride | 41 | 14 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 40 | 23 |
| Donepezil Hcl | Donepezil Hcl | 40 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 39 | 34 |
| Celecoxib | Celecoxib | 39 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 37 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 37 | 13 |
| Quetiapine Fumarate | Quetiapine Fumarate | 35 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 34 | suppressed |
| Januvia | Sitagliptin Phosphate | 33 | suppressed |
| Amoxicillin | Amoxicillin | 31 | 24 |
| Breo Ellipta | Fluticasone/Vilanterol | 31 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 31 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 31 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 30 | suppressed |
| Mirtazapine | Mirtazapine | 30 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 29 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 29 | suppressed |
| Synthroid | Levothyroxine Sodium | 28 | suppressed |
| Carvedilol | Carvedilol | 27 | suppressed |
| Famotidine | Famotidine | 27 | suppressed |
| Glipizide | Glipizide | 27 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 27 | suppressed |
| Rexulti | Brexpiprazole | 27 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 26 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 26 | suppressed |
| Ramipril | Ramipril | 25 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 24 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 23 | 23 |
| Methylprednisolone | Methylprednisolone | 23 | 21 |
| Metolazone | Metolazone | 23 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 23 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 22 | suppressed |
| Gemfibrozil | Gemfibrozil | 22 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 22 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 22 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Clonazepam | Clonazepam | 21 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 21 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 21 | suppressed |
| Ibuprofen | Ibuprofen | 20 | suppressed |
| Ondansetron Odt | Ondansetron | 20 | suppressed |
| Sure Comfort Pen Needle | Pen Needle, Diabetic | 20 | suppressed |
| Atenolol | Atenolol | 19 | suppressed |
| Ezetimibe | Ezetimibe | 18 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 17 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 17 | suppressed |
| Pulmicort Flexhaler | Budesonide | 17 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 16 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 16 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 16 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 15 | suppressed |
| Ozempic | Semaglutide | 15 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 14 | suppressed |
| Dilt-Xr | Diltiazem Hcl | 14 | suppressed |
| Lumigan | Bimatoprost | 14 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 13 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 13 | suppressed |
| Fluconazole | Fluconazole | 13 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 13 | suppressed |
| Memantine Hcl | Memantine Hcl | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Phenytoin | Phenytoin | 13 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 13 | 12 |
| Timolol Maleate | Timolol Maleate | 13 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 13 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 13 | suppressed |
| Baclofen | Baclofen | 12 | suppressed |
| Budesonide Ec | Budesonide | 12 | suppressed |
| Candesartan Cilexetil | Candesartan Cilexetil | 12 | suppressed |
| Myrbetriq | Mirabegron | 12 | suppressed |
| Olanzapine Odt | Olanzapine | 12 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 12 | suppressed |
| Rivastigmine | Rivastigmine | 12 | suppressed |
| Serevent Diskus | Salmeterol Xinafoate | 12 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 12 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 12 | suppressed |
| Cefdinir | Cefdinir | 11 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 11 | suppressed |
| Glipizide Er | Glipizide | 11 | suppressed |
| Irbesartan | Irbesartan | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $18.84 · 1 records | Vanda Pharmaceuticals Inc. | FANAPT | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error